MedChem 2014 is an EFMC Sponsored Event:
|
| Friday November 22, 2013 |
| 08:00 | Registration |
|
| 08:50 | Opening |
Dr Lieven MEERPOEL
(JANSSEN R&D, Belgium) |
| 09:00 | Cyclic Peptides: Constraining for Conformation vs Bioavailability |
Prof. David FAIRLIE
(UNIVERSITY OF QUEENSLAND, Brisbane, Australia) |
| 09:50 | Chemical Space: the Final Frontier. Nanocyclix' Mission: to Explore Strange New Worlds, to Boldly Go Where No Molecule Has Gone Before |
Dr Jan HOFLACK
(ONCODESIGN, Dijon, France) |
| 10:40 | Coffee Break |
|
| 11:15 | OC01 - Therapeutic Peptide Lead Finding & Optimization Using High-Throughput Screening of Arrays of Single- and Double-Constrained Clips-Peptides |
Prof. Peter TIMMERMAN
(PEPSCAN THERAPEUTICS, Lelystad, The Netherlands) |
| 11:35 | Design and Medical Application of Cyclic Peptides |
Dr Horst KESSLER
(TECHNISCHE UNIVERSITÄT MÜNCHEN, Garching, Germany) |
| 12:25 | Lunch Break |
|
| 14:00 | Macrocyclic Drug Design: Ghrelin Agonists as Potential GI Therapeutics |
Dr Hamid HOVEYDA
(EUROSCREEN, Woluwe-Saint-Lambert, Belgium) - (formerly at TRANZYME Pharma, Sherbrooke, Canada) |
| 14:50 | OC02 - Chemoenzymatic Synthesis of Modified Cyclic Peptides |
Prof. WAEL HOUSSEN
(UNIVERSITY OF ABERDEEN, Old Aberdeen, United Kingdom) |
| 15:10 | OC03 - Potent and Selective p53-Mdm2 Antagonists: Constrained and Unconstrained |
Prof. Alexander DÖMLING
(UNIVERSITY OF GRONINGEN, Groningen, The Netherlands) |
| 15:30 | Coffee Break and Poster session |
|
| 16:05 | A Novel Comprehensive Macrocycle-based Approach to Successful Drug Discovery and Development |
Dr Daniel OBRECHT
(POLYPHOR, Allschwil, Switzerland) |
| 16:55 | Synthetic Macrocycles can Unlock New Therapeutic Targets: Opportunities and Challenges in Infectious Diseases |
Dr Pierre RABOISSON
(JANSSEN PHARMACEUTICAL COMPANIES, Mechelen, Belgium) |
| 17:45 | Closing remarks |
|
|
